Supplemental nasogastric feeding in cystic fibrosis patients during treatment for acute exacerbation of chest disease.
The use of overnight, nasogastric, nutritional supplementation during hospitalization of children with cystic fibrosis (CF) receiving antibiotic therapy for acute exacerbations of respiratory disease was evaluated in 11 children (mean age = 7.75 years). Supplementary feeding significantly increased inpatient energy intake from 116 +/- 30% to 165 +/- 30% (P less than 0.001) of recommended dietary allowance with minimal effect on oral intake. It also resulted in significantly improved weight gains but neither increased energy intakes nor weights were sustained at short-term (mean = 5.7 weeks) or long-term (mean = 21.6 weeks) follow-up. The notion that short bursts of nasogastric feeding for inpatients with CF improve growth status is not supported. However, the study did show that treatment of chest infections alone does not positively affect spontaneous oral energy intake.
Daniels
L
L
Department of Nutrition and Dietetics, Adelaide Children's Hospital, Australia.
Davidson
G P
GP
Martin
A J
AJ
Pouras
T
T
D000293:Adolescent; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications / Q000178:diet therapy*; D002149:Energy Intake; D004750:Enteral Nutrition; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D012141:Respiratory Tract Infections / Q000178:diet therapy* / Q000209:etiology